Innovent Biologics

Traded on the St. Petersburg Stock Exchange
Innovent Biologics is a biopharmaceutical company in China. The company operates a platform for the discovery, development, and manufacture of antibody drug candidates in the fields of oncology, ophthalmology, immunology, and metabolic diseases
Innovent Biologics stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Innovent Biologics balance sheet

Report period2018 2019 2021 2022 2023
End date of the reporting period
Capitalization, CN¥
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Innovent Biologics cash flows

Report period2018 2019 2021 2022 2023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Innovent Biologics multipliers

Report period2018 2019 2021 2022 2023
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Innovent Biologics profitability

Report period2018 2019 2021 2022 2023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Innovent Biologics assets
Innovent Biologics cash flows

Innovent Biologics dividend policy

The company does not pay dividends

Innovent Biologics shares

TickerNameTypeNominal valueISINPrice
1801:HKInnovent BiologicsCommon share-KYG4818G1010HK$33
General information
Company nameInnovent Biologics
Tags#hong_kong_spb
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address168 Dongping Street Suzhou Industrial Park Suzhou 215123 China
Mailing address168 Dongping Street Suzhou Industrial Park Suzhou 215123 China
Websitewww.innoventbio.com